Question 1

What is the catalog number for Donanemab?

Accepted Answer

The catalog number for Donanemab is M36837.

Question 2

What sizes are available for Donanemab?

Accepted Answer

Donanemab is available in the following size(s): 1 g, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does Donanemab come in?

Accepted Answer

Donanemab is available in 7 different pack sizes.

Question 4

Is Donanemab in stock?

Accepted Answer

Donanemab is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Donanemab used for?

Accepted Answer

Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody that targets a pyroglutamate amyloid beta (Aβ) epitope at the N-terminus, showing potential for early Alzheimer's disease research .

Question 6

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 7

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 8

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Donanemab

Product Specifications

CAS Number

Stability

Purity

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-Human CD1b Recombinant Antibody (SAA2712)

Cyclin E1 (Phospho-T77) Rabbit mAb Antibody

Cyclin E1 (Phospho-T77) Rabbit mAb Antibody

ELOVL4 Antibody (C-term) Blocking Peptide

ELOVL4 Antibody (C-term) Blocking Peptide

2-[4- (3,4-Dichlorobenzyloxy) phenylethanol